Comparing heart valve prostheses for treating aortic stenosis
Official title: In-vitro Benchmarking of Currently Available Heart Valve Prostheses for Surgical and Percutaneous Treatment of Aortic Stenosis With Small Annulus, Followed by In-vivo Validation
Run by IRCCS Policlinico S. Donato · NCT06859255 · Data updated 2026-11-12
This study is testing how well different types of heart valve replacements work for people with severe aortic stenosis, especially those with smaller heart openings.
Quick facts
| Study type | Interventional |
|---|---|
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | IRCCS Policlinico S. Donato Academic / other |
| Locations | 2 sites (Bari, Apulia and 1 other locations) |
| Status | Recruiting |
| Started | February 7, 2025 |
| Main results expected | February 7, 2027 |
| Study ends | February 7, 2027 |
| Registry record updated | July 2, 2026 |
| Trial ID | NCT06859255 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients who have undergone surgical aortic valve replacement (SAVR) or transcatheter aortic valve implantation (TAVI) for severe aortic stenosis.
✕Probably not a fit
Patients with significant aortic regurgitation, recent revascularization, or other specific cardiac conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to evaluate the hemodynamic performance of various aortic valve prostheses through both in vitro and in vivo methods. It involves collecting data from standard clinical procedures, including echocardiograms and 4D Flow cardiac MRI, to assess the performance of these valves after surgical implantation. The study will last for 24 months, with patient involvement concluding 1-3 months post-intervention. The focus is on patients with severe aortic valve stenosis, particularly those with small aortic annuli, to understand how different prostheses perform under simulated and real conditions.
Why it matters
Potential benefit: If successful, this study could lead to improved outcomes for patients undergoing valve replacement for aortic stenosis.
How similar studies have gone: Other studies have explored similar methodologies in valve performance assessment, indicating potential for success in this area.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * patients who underwent SAVR or TAVI for severe aortic stenosis * implanted with valve models and sizes among those which we evaluated in vitro Exclusion Criteria: * treated or untreated aortic root/ascending aorta aneurysm * preoperative aortic regurgitation more than moderate * recent (\<12 weeks)/ concomitant revascularization * recent (\<12 weeks) ACS * PPI (permanent pacemaker implantation) * other than sinus rythm * Paravalvular leak (PVL) \> moderate.
Where it's running
-
Policlinico di Bari
Bari, Apulia, Italy Recruiting -
IRCCS Policlinico San Donato
San Donato, Lombardy, Italy Recruiting
Study contacts
- Study coordinator: Agnese Rossi, Study Coordinator
- Email: agnese.rossi@grupposandonato.it
- Phone: 00393409009040
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Hydra THV Transfemoral Valve Implantation in Severe Aortic Stenosis
This registry tests how safely and effectively the Hydra THV works when implanted through the femoral artery in adults with severe symptomatic aortic stenosis.
-
Noninvasive ECG Monitoring to Support Early Discharge After TAVI for Conduction Disorders
A noninvasive ECG monitoring approach is tested to see if it safely allows patients with conduction issues after TAVI to go home earlier.
-
FAPI-PET imaging to see heart tissue changes after TAVI for aortic stenosis
Using FAPI-PET scans, doctors will see if heart scarring and function improve after TAVI in people with severe aortic stenosis compared with those treated with medication alone.
-
Registry for patients with severe aortic valve stenosis undergoing TAVR with Myval valve
This study is testing how often heart rhythm problems happen and if patients need a pacemaker after getting a new heart valve through TAVR using the Myval valve.
-
Personalized antithrombotic therapy for patients after aortic valve replacement
This study is testing if a personalized blood-thinning treatment can help people who have had aortic valve replacement feel better and avoid complications compared to standard treatment.
-
Evaluating treatment options for aortic valve stenosis
This study is testing how different treatments for aortic valve stenosis, like surgery and other options, affect patients' quality of life and survival.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.